Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

1H and 31P Magnetic Resonance Spectroscopic Metabolomic Imaging: Assessing Mitogen-Activated Protein Kinase Inhibition in Melanoma

Cells(2024)10.3390/cells13141220Source: DataRank Database

1H and 31P Magnetic Resonance Spectroscopic Metabolomic Imaging: Assessing Mitogen-Activated Protein Kinase Inhibition in Melanoma is a research paper published in Cells (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.64)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Stepan Orlovskiy ORCID,Fernando Arias‐Mendoza,David Nelson ORCID,Kavindra Nath ORCID,Pradeep Kumar Gupta ORCID

Live enrichment

PubMed:39056801 PMC:PMC11274771 OpenAlex:https://openalex.org/W4400809737

NIH

Grant: R01CA250102

NIH

Grant: R01CA228457

NIH

Grant: R01CA268601

NIH

Grant: R21CA280523

NIH HHS

Grant: R01CA250102, R01CA228457, R01CA268601, R21CA280523.

National Institutes of Health

Grant: 5R01CA268601-03

Metabolic Imaging of Targeted Therapies in Cancer

National Institutes of Health

Grant: 5R01CA228457-03

Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition

National Institutes of Health

Grant: 5R01CA250102-05

Melanoma: Metabolic Biomarkers of Response to Targeted Therapy

National Institutes of Health

Grant: 1R21CA280523-01A1

Translation of Noninvasive Metabolic Biomarkers to Targeted Therapy for Cancer

FWCI

0.64

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/13/14/1220/pdf?version=1721389825

publisherhttps://www.mdpi.com/2073-4409/13/14/1220/pdf?version=1721389825

publisherhttps://www.mdpi.com/2073-4409/13/14/1220/pdf

journalhttps://doi.org/10.3390/cells13141220

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39056801

Fields of Study

Melanoma and MAPK PathwaysComputational Drug Discovery Methodsbioluminescence and chemiluminescence research0303 health sciences03 medical and health sciencesMelanomaHumansMetabolomicsCell Line, TumorProtein Kinase InhibitorsProto-Oncogene Proteins B-rafMagnetic Resonance SpectroscopyMitogen-Activated Protein KinasesProton Magnetic Resonance Spectroscopy

MeSH Terms

HumansMelanomaMagnetic Resonance SpectroscopyMitogen-Activated Protein KinasesCell Line, TumorProtein Kinase InhibitorsProto-Oncogene Proteins B-rafMetabolomicsProton Magnetic Resonance Spectroscopy

Keywords

MelanomaMAPK/ERK pathwayMEK inhibitorMagnetic resonance imagingCancer researchMedicineProtein kinase AMetabolic pathwayKinaseBiologyInternal medicineBiochemistryMetabolismOxygen consumption rateGlucose uptakeExtracellular Acidification RateTrametinibLactate Production1H/31p Magnetic Resonance SpectroscopyProto-Oncogene Proteins B-rafMagnetic Resonance SpectroscopyQH573-671Proton Magnetic Resonance Spectroscopy<sup>1</sup>H/<sup>31</sup>P magnetic resonance spectroscopyArticleCell Line, TumorHumansMetabolomicsMitogen-Activated Protein KinasesCytologyProtein Kinase Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being